
X4 Pharmaceuticals XFOR
$ 3.01
1.35%
X4 Pharmaceuticals ROA Ratio | XFOR
Annual ROA Ratio X4 Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -27.27 | -25.57 | -68.7 | -60.33 | -75.69 | -50.57 | -32.86 | -119.49 | -41.69 | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -25.57 | -119.49 | -55.8 |
Quarterly ROA Ratio X4 Pharmaceuticals
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30.82 | -40.34 | -58.43 | -50.73 | -69.68 | -72.05 | -4.44 | -50.8 | -36.6 | -17.34 | -92.59 | -65.76 | -70.09 | -88.07 | -82.12 | -87.13 | -100.45 | -97.88 | -85.57 | -77.96 | -62.29 | -58.66 | -55.42 | -45.95 | -37.72 | -40.79 | -40.19 | -51.27 | -138.63 | -142.85 | -144.72 | -138.1 | -57.76 | -51.65 | -46.78 | -41.69 | -14.28 | -7.02 | -6.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -4.44 | -144.72 | -63.11 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Graybug Vision
GRAY
|
-217.5 | - | -11.23 % | $ 9.65 M | ||
|
Galera Therapeutics
GRTX
|
2071.28 | - | -32.59 % | $ 7.61 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-34.54 | - | 1.35 % | $ 17.8 M | ||
|
Novavax
NVAX
|
37.42 | $ 7.47 | -3.24 % | $ 1.21 B | ||
|
Hepion Pharmaceuticals
HEPA
|
-269.64 | - | -18.79 % | $ 39.3 K | ||
|
Hoth Therapeutics
HOTH
|
-164.0 | - | - | $ 18.8 M | ||
|
IMARA
IMRA
|
-21.78 | - | 15.96 % | $ 663 M | ||
|
KalVista Pharmaceuticals
KALV
|
-32.65 | - | - | $ 1.45 B | ||
|
KemPharm
KMPH
|
29.23 | - | -0.34 % | $ 200 M | ||
|
Kezar Life Sciences
KZR
|
-73.11 | - | - | $ 53.3 M | ||
|
Lixte Biotechnology Holdings
LIXT
|
-47.74 | - | - | $ 63.4 M | ||
|
Magenta Therapeutics
MGTA
|
-30.58 | - | -7.74 % | $ 41.6 M | ||
|
NovaBay Pharmaceuticals
NBY
|
-6981.52 | - | - | $ 11.3 M | ||
|
NeuroBo Pharmaceuticals
NRBO
|
-116.63 | - | 0.43 % | $ 12 M | ||
|
OncoCyte Corporation
OCX
|
-0.19 | - | 17.22 % | $ 355 K | ||
|
Onconova Therapeutics
ONTX
|
86.37 | - | -0.47 % | $ 21 M | ||
|
Opthea Limited
OPT
|
-286.61 | - | - | $ 1.2 B | ||
|
Verastem
VSTM
|
-85.0 | $ 6.33 | -7.8 % | $ 439 M | ||
|
BiomX
PHGE
|
-625.96 | $ 1.85 | 14.2 % | $ 3.02 M | ||
|
Pieris Pharmaceuticals
PIRS
|
-70.04 | - | -15.58 % | $ 1.22 B | ||
|
Plus Therapeutics
PSTV
|
-137.13 | - | - | $ 301 M | ||
|
Pluristem Therapeutics
PSTI
|
-95.75 | - | -1.9 % | $ 33.3 M | ||
|
Qualigen Therapeutics
QLGN
|
-54.24 | - | 5.59 % | $ 1.16 M | ||
|
Qilian International Holding Group Limited
QLI
|
-4.6 | - | -6.08 % | $ 184 M | ||
|
Cassava Sciences
SAVA
|
-76.86 | - | - | $ 110 M | ||
|
Selecta Biosciences
SELB
|
-43.96 | - | -8.69 % | $ 126 M | ||
|
Sangamo Therapeutics
SGMO
|
-205.76 | - | - | $ 50.4 M | ||
|
Salarius Pharmaceuticals
SLRX
|
-113.22 | - | - | $ 2.64 M | ||
|
Sensei Biotherapeutics
SNSE
|
-92.07 | - | - | $ 17.5 M | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
-107.57 | - | - | $ 826 K | ||
|
Synthetic Biologics
SYN
|
-62.08 | - | 1.32 % | $ 16.2 M | ||
|
Synlogic
SYBX
|
-6.51 | - | - | $ 7.07 M | ||
|
Virios Therapeutics, LLC
VIRI
|
-37.99 | - | 2710.01 % | $ 72.9 M | ||
|
Vallon Pharmaceuticals
VLON
|
-137.96 | - | -6.47 % | $ 5.76 M | ||
|
Vaxart
VXRT
|
2.88 | - | -25.06 % | $ 46.3 M | ||
|
XOMA Corporation
XOMA
|
11.63 | - | - | $ 485 M | ||
|
Repare Therapeutics
RPTX
|
-47.98 | - | - | $ 112 M | ||
|
Sesen Bio
SESN
|
-198.56 | - | 7.29 % | $ 127 M | ||
|
Windtree Therapeutics
WINT
|
-6.41 | - | - | $ 26.8 M | ||
|
Trean Insurance Group
TIG
|
-4.17 | - | - | $ 316 M | ||
|
SQZ Biotechnologies Company
SQZ
|
-79.54 | - | 57.95 % | $ 12.8 M | ||
|
MEI Pharma
MEIP
|
-166.66 | - | 10.43 % | $ 20.5 M | ||
|
Palatin Technologies
PTN
|
-98.29 | - | - | $ 13 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Lyra Therapeutics
LYRA
|
-80.09 | - | - | $ 24.9 M | ||
|
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | ||
|
Applied Therapeutics
APLT
|
-121.84 | - | - | $ 8.42 M |